
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT
- About


Natural Alternatives International (NAII)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/28/2025: NAII (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type Stock | Historic Profit -44.66% | Avg. Invested days 28 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 19.90M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.63 | 52 Weeks Range 2.57 - 6.88 | Updated Date 06/29/2025 |
52 Weeks Range 2.57 - 6.88 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.39 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -6.56% | Operating Margin (TTM) 7.87% |
Management Effectiveness
Return on Assets (TTM) -3.75% | Return on Equity (TTM) -10.25% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 67902418 | Price to Sales(TTM) 0.16 |
Enterprise Value 67902418 | Price to Sales(TTM) 0.16 | ||
Enterprise Value to Revenue 0.54 | Enterprise Value to EBITDA 74.97 | Shares Outstanding 6178900 | Shares Floating 4878116 |
Shares Outstanding 6178900 | Shares Floating 4878116 | ||
Percent Insiders 21.59 | Percent Institutions 33.51 |
Upturn AI SWOT
Natural Alternatives International

Company Overview
History and Background
Natural Alternatives International (NAII) was founded in 1980. It initially focused on contract manufacturing and private labeling of nutritional supplements. Over time, it has evolved into a leading formulator, manufacturer, and marketer of customized nutritional supplements.
Core Business Areas
- Contract Manufacturing: NAII provides contract manufacturing services to companies that market and distribute nutritional supplements, often under their own brands. This includes formulation, ingredient sourcing, blending, tableting, encapsulation, and packaging.
- Private Labeling: NAII offers private label services, creating and packaging nutritional supplements under a client's brand name. This allows clients to quickly bring new products to market without investing heavily in R&D and manufacturing infrastructure.
- Branded Products: NAII also develops, markets, and sells its own branded nutritional supplements under the CarnoSynu00ae and SR CarnoSynu00ae brands and direct to consumer via Jolted. These products often feature its patented ingredients and formulations.
Leadership and Structure
Mark A. LeDoux is the Chairman and Chief Executive Officer. The company has a traditional hierarchical structure with departments for manufacturing, sales, marketing, R&D, finance, and operations.
Top Products and Market Share
Key Offerings
- CarnoSynu00ae Beta-Alanine: CarnoSynu00ae is a patented form of beta-alanine, an amino acid that helps buffer lactic acid in muscles, improving athletic performance. It's licensed to various supplement manufacturers and food and beverage companies. Market share data is difficult to ascertain precisely, but NAII is a major supplier of beta-alanine. Competitors include other beta-alanine manufacturers and alternative performance-enhancing supplements.
- SR CarnoSynu00ae Sustained Release Beta-Alanine: SR CarnoSynu00ae is a sustained-release version of CarnoSynu00ae, designed for improved bioavailability and reduced paresthesia (tingling sensation). Similar to CarnoSynu00ae, it is licensed to other companies. Competitors are the same as CarnoSynu00ae.
- Custom Formulations and Manufacturing: NAII offers comprehensive custom formulation and manufacturing services for a wide array of nutritional supplements. It is difficult to assess market share within this segment. Competitors include other contract manufacturers like Nutra Manufacturing, Robinson Pharma and Captek Softgel International.
Market Dynamics
Industry Overview
The nutritional supplement industry is experiencing growth driven by increasing consumer awareness of health and wellness, an aging population, and rising healthcare costs. The market is highly competitive and regulated.
Positioning
NAII is positioned as a premium provider of high-quality, science-backed ingredients and custom manufacturing services. Its competitive advantages include its patented ingredients (CarnoSynu00ae), scientific expertise, and strong relationships with leading brands.
Total Addressable Market (TAM)
The global dietary supplements market is estimated to reach hundreds of billions of dollars. NAII is positioned to capture a share of this market through its branded ingredients and contract manufacturing services. Exact TAM breakdown for segments NAII operates in is unavailable.
Upturn SWOT Analysis
Strengths
- Patented ingredients (CarnoSynu00ae)
- Strong R&D capabilities
- High-quality manufacturing standards
- Established relationships with leading brands
- Experienced management team
Weaknesses
- Reliance on a few key ingredients (CarnoSynu00ae)
- Relatively small size compared to major competitors
- Exposure to raw material price fluctuations
- Limited brand recognition beyond CarnoSynu00ae
Opportunities
- Expanding into new markets and geographies
- Developing new patented ingredients
- Acquiring complementary businesses
- Increasing consumer awareness of CarnoSynu00ae benefits
- Growth in personalized nutrition
Threats
- Increased competition from other supplement manufacturers
- Changing regulations and labeling requirements
- Adverse publicity related to supplement safety
- Economic downturn affecting consumer spending
- Patent expiration on key ingredients
Competitors and Market Share
Key Competitors
- Nutrabolt (Private)
- Glanbia (GLB.I)
- Lonza (LONN.SW)
Competitive Landscape
NAII's advantages include its patented ingredients and strong R&D capabilities. Disadvantages include its smaller size and limited brand recognition compared to larger competitors.
Growth Trajectory and Initiatives
Historical Growth: Historical growth has been driven by demand for CarnoSynu00ae and growth in the contract manufacturing business. Requires specific historical data.
Future Projections: Future growth projections would depend on analyst estimates and management guidance. Factors include market trends, new product introductions, and acquisitions.
Recent Initiatives: Recent initiatives include expanding CarnoSynu00ae applications, investing in R&D, and seeking strategic partnerships.
Summary
Natural Alternatives International possesses strengths in patented ingredients and contract manufacturing, but its small size and reliance on CarnoSynu00ae are weaknesses. The growing supplement market offers opportunities. They should monitor increasing competition and changing regulations.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings (SEC)
- Industry reports
- Press releases
Disclaimers:
This analysis is based on publicly available information and is for informational purposes only. It is not financial advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Natural Alternatives International
Exchange NASDAQ | Headquaters Carlsbad, CA, United States | ||
IPO Launch date 1987-03-13 | Chairman of the Board & CEO Mr. Mark A. LeDoux J.D. | ||
Sector Consumer Defensive | Industry Packaged Foods | Full time employees 296 | Website https://www.nai-online.com |
Full time employees 296 | Website https://www.nai-online.com |
Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States and internationally. It operates through two segments: Private-Label Contract Manufacturing, and Patent and Trademark Licensing. The company offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. It also provides strategic partnering services, such as customized product formulation, clinical study design and support, manufacturing, marketing support, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management, packaging and delivery system design, regulatory review, and international product registration assistance. In addition, the company sells beta-alanine ingredient under the CarnoSyn and SR CarnoSyn names. The company manufactures products in various forms, including capsules, tablets, chewable wafers, and powders. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores. Natural Alternatives International, Inc. was founded in 1980 and is headquartered in Carlsbad, California.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.